The global flexible manufacturing systems for pharmaceutical industry size was valued at $1,962.2 million in 2021 and is projected to reach $3,319.7 million by 2031, registering a CAGR of 5.3% from 2022 to 2031.
A flexible manufacturing system for pharmaceuticals is a system that includes specialized machineries, processes, and operations involved in pharmaceutical manufacturing that are capable of being modified and changed within a short span of time to cope with sudden market changes.
Government and private agencies across the world keep a close eye on the pharmaceutical industry owing to its inherent nature of being associated with the lives of people and animals. Moreover, it is one of the few industries that is highly affected by politics across the world. Along with this, diseases evolve and often develop immunity to medicines. Such factors drive the demand for flexible manufacturing systems for pharmaceutical industry, as they allow quick response to market changes.
Increase in number of patients suffering from diseases such as heart diseases, diabetes, and arthritis rare diseases has significantly increased owing to rise in geriatric population. Furthermore, rise in number of patients has increased the demand for in pharmaceutical industry. These factors positively influence the growth of the flexible manufacturing systems for pharmaceutical industry. However, requirement for highly skilled professionals for operating and developing flexible manufacturing systems for pharmaceutical is a major restraint in the industry. Furthermore, rise in pharmaceutical industry in the emerging nations provides lucrative growth opportunities for the industry.
The global flexible manufacturing systems for pharmaceutical industry is segmented on the basis of type, technology, end user, and region. By type, the market is categorized into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing. On the basis of technology, it is segmented into software and hardware. By end user, it is bifurcated into large pharmaceutical manufacturers and medium & small pharmaceutical manufacturers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players operating in the global market have adopted key strategies such as product launch, partnership, and acquisition to strengthen their market outreach and sustain the stiff competition in the market.
A flexible manufacturing system for pharmaceuticals is a system that includes specialized machineries, processes, and operations involved in pharmaceutical manufacturing that are capable of being modified and changed within a short span of time to cope with sudden market changes.
Government and private agencies across the world keep a close eye on the pharmaceutical industry owing to its inherent nature of being associated with the lives of people and animals. Moreover, it is one of the few industries that is highly affected by politics across the world. Along with this, diseases evolve and often develop immunity to medicines. Such factors drive the demand for flexible manufacturing systems for pharmaceutical industry, as they allow quick response to market changes.
Increase in number of patients suffering from diseases such as heart diseases, diabetes, and arthritis rare diseases has significantly increased owing to rise in geriatric population. Furthermore, rise in number of patients has increased the demand for in pharmaceutical industry. These factors positively influence the growth of the flexible manufacturing systems for pharmaceutical industry. However, requirement for highly skilled professionals for operating and developing flexible manufacturing systems for pharmaceutical is a major restraint in the industry. Furthermore, rise in pharmaceutical industry in the emerging nations provides lucrative growth opportunities for the industry.
The global flexible manufacturing systems for pharmaceutical industry is segmented on the basis of type, technology, end user, and region. By type, the market is categorized into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing. On the basis of technology, it is segmented into software and hardware. By end user, it is bifurcated into large pharmaceutical manufacturers and medium & small pharmaceutical manufacturers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players operating in the global market have adopted key strategies such as product launch, partnership, and acquisition to strengthen their market outreach and sustain the stiff competition in the market.
COMPETITION ANALYSIS
Key companies profiled in the flexible manufacturing systems for pharmaceutical industry report include Angstrom Technology, Biologics Modular, LLC, Chempharm, Cytiva, ESC (Environmental Systems Corporation), Exyte GmbH, G-CON Manufacturing, Germfree Laboratories Inc., IPM Technologies, KeyPlants Ab, ModuleCo Ltd., Modwave LLC, Nicomac Srl, NNE, Pharmadule Morimatsu AB, PR Pharma, and Engineers Pvt. Ltd.KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flexible manufacturing systems for pharmaceutical industry market analysis from 2021 to 2031 to identify the prevailing flexible manufacturing systems for pharmaceutical industry market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the flexible manufacturing systems for pharmaceutical industry market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global flexible manufacturing systems for pharmaceutical industry market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Modular manufacturing
- Data-driven manufacturing
- Single-use manufacturing
- Continuous manufacturing
By Technology
- Hardware
- Software
By End User Industry
- Large Pharmaceutical Manufacturers
- Method
- Machine Flexibility
- Volume Flexibility
- Medium and Small Pharmaceutical Manufacturers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Vietnam
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- UAE
- South Africa
- Kenya
Key Market Players
- Angstrom Technology
- Biologics Modular, LLC
- Chempharm
- Cytiva
- ESC (Environmental Systems Corporation)
- Exyte GmbH
- G-CON Manufacturing
- Germfree Laboratories Inc.
- IPM Technologies
- KeyPlants Ab
- ModuleCo Ltd.
- Modwave LLC
- Nicomac Srl
- NNE
- Pharmadule Morimatsu AB
- PR Pharma Engineers Pvt. Ltd.
- Univercells Technologies
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE
CHAPTER 5: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY
CHAPTER 6: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY
CHAPTER 7: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Flexible Manufacturing Systems for Pharmaceutical Industry Market," the flexible manufacturing systems for pharmaceutical industry market size was valued at $2 billion in 2021, and is estimated to reach $3.3 billion by 2031, growing at a CAGR of 5.3% from 2022 to 2031.By type, the market is segmented into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing. Among these, the modular manufacturing segment accounted for the highest market share in 2021, and continuous manufacturing is expected to witness significant growth during the forecast period, owing to its various advantageous features that reduce the overall cost of production and increase the reliability of the process. Moreover, on the basis of technology, software segment is expected to grow at a higher CAGR in the coming years. The market is mainly driven by rise in geriatric population and increased investment in healthcare industry. However, requirement for skilled professionals is expected to limit growth of the industry.
In 2021, North America dominated the global flexible manufacturing systems for pharmaceutical industry market growth, in terms of revenue followed by Asia-Pacific and Europe. Moreover, the market in Asia-Pacific region is expected to grow with a high CAGR, owing to a rise in population and high investments in pharmaceutical sector in the region.
There are various advantageous features of flexible manufacturing systems such as higher manufacturing efficiency and quick adaptability to demand fluctuations that enables pharmaceutical manufacturers to enhance their profit margin. Increase in number of elderly people across the world has led to increasing the number of patients suffering from various rare and common diseases. This is expected to drive demand in pharmaceutical industry. Furthermore, growth of pharmaceutical industry in emerging countries and advanced healthcare facilities in developed countries have propelled the flexible manufacturing systems for pharmaceutical industry.
Furthermore, on the basis of end-user, the medium and small pharmaceutical manufacturers are anticipated to grow rapidly, with a CAGR during the forecast period, owing to the rapid growth of the healthcare industry in developing countries.
For instance, according to the India Brand Equity Foundation, by 2022, the Indian healthcare infrastructure is expected to reach a value of $ 349.1 billion and by 2025, the Indian e-health market is estimated to reach $ 10.6 billion.
However, during the pandemic lockdown, various players in the flexible manufacturing systems for pharmaceutical industry market downgraded their business in countries such as China, the U.S., and India owing to disruption of their supply chains. This break directly impacted companies involved in flexible manufacturing systems for pharmaceutical industry development. In addition, the extensive focus of major countries on the development of vaccines has positively influenced the growth of the market. However, the reopening of research facilities is anticipated to boost the flexibility of manufacturing systems for the pharmaceutical industry.
Key companies profiled in the flexible manufacturing systems for pharmaceutical industry market forecast report include Angstrom Technology, Biologics Modular, LLC, Chempharm, Cytiva, ESC (Environmental Systems Corporation), Exyte GmbH, G-CON Manufacturing, Germfree Laboratories Inc., IPM Technologies, KeyPlants Ab, ModuleCo Ltd., Modwave LLC, Nicomac Srl, NNE, Pharmadule Morimatsu AB, PR Pharma, and Engineers Pvt. Ltd.
Key Findings of the Study
- The report provides an extensive flexible manufacturing systems for pharmaceutical industry market analysis of the current and emerging opportunities. flexible manufacturing systems for pharmaceutical industry market trends and dynamics.
- Depending on type, the modular manufacturing held the largest flexible manufacturing systems for pharmaceutical industry market share, in terms of revenue in 2021 and the continuous manufacturing segment is projected to grow at a significant CAGR during the forecast period.
- Depending on the technology, hardware segment dominated the market in terms of revenue in 2021.
- By end-user, the medium and small pharmaceutical manufacturers segment registered the highest revenue in 2021.
- The report provides an extensive analysis of flexible manufacturing systems for pharmaceutical industry market trends and dynamics.
- The key players within the flexible manufacturing systems for pharmaceutical industry are profiled in this report, and their strategies are analyzed thoroughly, which helps understand competitive outlook of the radiology information system industry.
- The report provides an extensive analysis of the current trends and emerging opportunities in the market.
- In-depth flexible manufacturing systems for pharmaceutical industry market analysis is conducted by constructing estimations for the key segments between 2022 and 2031.
Companies Mentioned
- Angstrom Technology
- Biologics Modular, LLC
- Chempharm
- Cytiva
- Esc (Environmental Systems Corporation)
- Exyte GmbH
- G-Con Manufacturing
- Germfree Laboratories Inc.
- Ipm Technologies
- Keyplants Ab
- Moduleco Ltd.
- Modwave LLC
- Nicomac Srl
- Nne
- Pharmadule Morimatsu Ab
- Pr Pharma Engineers Pvt. Ltd.
- Univercells Technologies
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
